Anika Therapeutics (ANIK) Restructuring Costs (2013)
Anika Therapeutics' (ANIK) quarterly Restructuring Costs came in at $111178.0 in Q2 2013, down 18.01% quarter-over-quarter from $135607.0 in Q1 2013.
Powered by 
Analysis
Anika Therapeutics (ANIK) Restructuring Costs (2013) Analysis & Trends
Anika Therapeutics (ANIK) has reported Restructuring Costs for 1 consecutive years, with $111178.0 the latest figure, recorded in Q2 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn |